Qiagen N.V.
QGEN- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001015820
No open-market purchases or sales by Qiagen N.V. insiders were filed in the last 90 days; 337 institutions reported holding it in 13F filings for Q2 2026, worth $5.68B in total; no superinvestor holds it.
Members of Congress who traded QGEN
Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.
- Trades
- 4
- Filings
- 3
- Members
- 2
- Buys / sells
- 1 / 3
- Estimated volume
- $32.0K
- Sum of range midpoints
| Member | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
| Peter WelchDemocrat · House · VT | 2 | 1 / 1 | $16.0K | Mar 24, 2020 | Apr 3, 2020 |
| Donna E. ShalalaDemocrat · House · FL | 2 | 0 / 2 | $16.0K | Jan 23, 2019 | Apr 27, 2020 |
Trades
Every reported trade in Qiagen N.V., newest filings first.
| Member | Asset | Type | Owner | Traded | Filed | Delay | Amount | Source |
|---|---|---|---|---|---|---|---|---|
| Donna E. ShalalaDemocrat · House · FL | QGENQiagen N.V. Common Shares | Sell (partial) | Self | Jan 23, 2019 | Apr 27, 2020 | 460 daysLate | $1K-$15K | Filing |
| Donna E. ShalalaDemocrat · House · FL | QGENQiagen N.V. Common Shares | Sell | Self | Jan 9, 2019 | Apr 27, 2020 | 474 daysLate | $1K-$15K | Filing |
| Peter WelchDemocrat · House · VT | QGENQiagen N.V. Common Shares | Sell | Self | Mar 24, 2020 | Apr 3, 2020 | 10 days | $1K-$15K | Filing |
| Peter WelchDemocrat · House · VT | QGENQiagen N.V. Common Shares | Buy | Self | Feb 27, 2020 | Mar 10, 2020 | 12 days | $1K-$15K | Filing |
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.